These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32359471)

  • 1. Split AAV-Mediated Gene Therapy Restores Ureagenesis in a Murine Model of Carbamoyl Phosphate Synthetase 1 Deficiency.
    Nitzahn M; Allegri G; Khoja S; Truong B; Makris G; Häberle J; Lipshutz GS
    Mol Ther; 2020 Jul; 28(7):1717-1730. PubMed ID: 32359471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional disruption of hepatic carbamoyl phosphate synthetase 1 in mice results in hyperammonemia without orotic aciduria and can be corrected by liver-directed gene therapy.
    Khoja S; Nitzahn M; Hermann K; Truong B; Borzone R; Willis B; Rudd M; Palmer DJ; Ng P; Brunetti-Pierri N; Lipshutz GS
    Mol Genet Metab; 2018 Aug; 124(4):243-253. PubMed ID: 29801986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic glutamine synthetase augmentation enhances ammonia detoxification.
    Soria LR; Nitzahn M; De Angelis A; Khoja S; Attanasio S; Annunziata P; Palmer DJ; Ng P; Lipshutz GS; Brunetti-Pierri N
    J Inherit Metab Dis; 2019 Nov; 42(6):1128-1135. PubMed ID: 30724386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A constitutive knockout of murine carbamoyl phosphate synthetase 1 results in death with marked hyperglutaminemia and hyperammonemia.
    Khoja S; Nitzahn M; Truong B; Lambert J; Willis B; Allegri G; Rüfenacht V; Häberle J; Lipshutz GS
    J Inherit Metab Dis; 2019 Nov; 42(6):1044-1053. PubMed ID: 30835861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Study of Carbamoyl Phosphate Synthetase 1 Deficiency Sheds Light on the Mechanism for Switching On/Off the Urea Cycle.
    Díez-Fernández C; Gallego J; Häberle J; Cervera J; Rubio V
    J Genet Genomics; 2015 May; 42(5):249-60. PubMed ID: 26059772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting CPS1 in the treatment of Carbamoyl phosphate synthetase 1 (CPS1) deficiency, a urea cycle disorder.
    Diez-Fernandez C; Häberle J
    Expert Opin Ther Targets; 2017 Apr; 21(4):391-399. PubMed ID: 28281899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CPS1: Looking at an ancient enzyme in a modern light.
    Nitzahn M; Lipshutz GS
    Mol Genet Metab; 2020 Nov; 131(3):289-298. PubMed ID: 33317798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of human carbamoyl phosphate synthetase: deciphering the on/off switch of human ureagenesis.
    de Cima S; Polo LM; Díez-Fernández C; Martínez AI; Cervera J; Fita I; Rubio V
    Sci Rep; 2015 Nov; 5():16950. PubMed ID: 26592762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unfavorable clinical outcomes in patients with carbamoyl phosphate synthetase 1 deficiency.
    Choi Y; Oh A; Lee Y; Kim GH; Choi JH; Yoo HW; Lee BH
    Clin Chim Acta; 2022 Feb; 526():55-61. PubMed ID: 34973183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence of carbamoyl phosphate synthetase 1 (CPS1) deficiency in Turkish patients: characterization of a founder mutation by use of recombinant CPS1 from insect cells expression.
    Hu L; Diez-Fernandez C; Rüfenacht V; Hismi BÖ; Ünal Ö; Soyucen E; Çoker M; Bayraktar BT; Gunduz M; Kiykim E; Olgac A; Pérez-Tur J; Rubio V; Häberle J
    Mol Genet Metab; 2014 Dec; 113(4):267-73. PubMed ID: 25410056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic, structural and biochemical basis of carbamoyl phosphate synthetase 1 deficiency.
    Martínez AI; Pérez-Arellano I; Pekkala S; Barcelona B; Cervera J
    Mol Genet Metab; 2010 Dec; 101(4):311-23. PubMed ID: 20800523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of carbamoyl-phosphate synthetase (CPS1) deficiency using human recombinant CPS1 as a key tool.
    Diez-Fernandez C; Martínez AI; Pekkala S; Barcelona B; Pérez-Arellano I; Guadalajara AM; Summar M; Cervera J; Rubio V
    Hum Mutat; 2013 Aug; 34(8):1149-59. PubMed ID: 23649895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbamoylphosphate synthetase 1 (CPS1) deficiency: clinical, biochemical, and molecular characterization in Malaysian patients.
    Ali EZ; Khalid MK; Yunus ZM; Yakob Y; Chin CB; Abd Latif K; Hock NL
    Eur J Pediatr; 2016 Mar; 175(3):339-46. PubMed ID: 26440671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and CPS1 variants in Chinese patients with carbamoyl phosphate synthetase 1 deficiency.
    Dong H; Sang T; Ma X; Song J; Chen Z; Zhang H; Jin Y; Li M; Dong D; Sun L; Zhu Z; Zhang Y; Yang Y
    BMC Pediatr; 2024 Aug; 24(1):539. PubMed ID: 39174957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of carbamoyl-phosphate synthase 1 significantly improves ureagenesis of human liver HepaRG cells only when cultured under shaking conditions.
    Adam AAA; van der Mark VA; Ruiter JPN; Wanders RJA; Oude Elferink RPJ; Chamuleau RAFM; Hoekstra R
    Mitochondrion; 2019 Jul; 47():298-308. PubMed ID: 30802674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular, biochemical, and clinical analyses of five patients with carbamoyl phosphate synthetase 1 deficiency.
    Fan L; Zhao J; Jiang L; Xie L; Ma J; Li X; Cheng M
    J Clin Lab Anal; 2020 Apr; 34(4):e23124. PubMed ID: 31749211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling the therapeutic potential of carbamoyl phosphate synthetase 1 (CPS1) in human diseases.
    Zhang L; Zou Y; Lu Y; Li Z; Gao F
    Bioorg Chem; 2023 Jan; 130():106253. PubMed ID: 36356370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding carbamoyl phosphate synthetase (CPS1) deficiency by using the recombinantly purified human enzyme: effects of CPS1 mutations that concentrate in a central domain of unknown function.
    Díez-Fernández C; Hu L; Cervera J; Häberle J; Rubio V
    Mol Genet Metab; 2014 Jun; 112(2):123-32. PubMed ID: 24813853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variant in the allosteric domain of CPS1 protein associated with effectiveness of N-carbamoyl glutamate therapy in neonatal onset CPS1 deficiency.
    Gragnaniello V; Gueraldi D; Puma A; Commone A; Loro C; Cazzorla C; Häberle J; Burlina AB
    J Pediatr Endocrinol Metab; 2023 Sep; 36(9):873-878. PubMed ID: 37427576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion.
    Eriksen PL; Vilstrup H; Rigbolt K; Suppli MP; Sørensen M; Heebøll S; Veidal SS; Knop FK; Thomsen KL
    Liver Int; 2019 Nov; 39(11):2094-2101. PubMed ID: 31386258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.